Braveheart Bio reportedly pricing IPO above marketing range
Go back to Braveheart Bio reportedly pricing IPO above marketing range| (NASDAQ: BRVE) | Delayed: 25.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.02 | 52 Week High | $ | |||
| Open | $25.02 | 52 Week Low | $ | |||
| Day High | $25.02 | P/E | N/A | |||
| Day Low | $25.02 | EPS | $ | |||
| Volume | 384 | |||||

